HYMR1

Tuesday, April 30, 2013

Kcentra, Octaplex, USA 4-Factor PCCs

In the coming weeks we will live update how we will incorporate the new 4-factor PCC products into our institutional formulary and practice.
Exciting developments to come!

Featured Post

Giapreza - A Closer Look at the Pharmacology of Ang2

Angiotensin-II (Ang2) is now an FDA approved vasopressor. With this new addition to the available options, experts are combing over the ...